Difficulty: Medium
Average Score: 67%
Practice
A 23-year-old woman with a history of seizure disorder is planning to become pregnant. She realizes that being on this medication during pregnancy can have fetal effects of mental retardation. Which of the following agents would likely produce a newborn with the lowest intelligence quotient (IQ)?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Valproic acid. Valproic acid is known to be associated with the highest risk of cognitive impairment in newborns when compared to other antiepileptic drugs. This is due to its teratogenic effects on the developing fetal brain, leading to a higher likelihood of mental retardation and lower intelligence quotient (IQ) in the newborn.
Carbamazepine (option A), Lamotrigine (option B), and Phenytoin (option C) are also commonly used antiepileptic drugs. However, they are generally considered to have a lower risk of cognitive impairment compared to Valproic acid. While they still pose some risks during pregnancy, they are often preferred over Valproic acid when managing seizure disorders in women of childbearing age due to their relatively safer profiles in terms of fetal neurodevelopment.
From an educational context, it is crucial for healthcare providers to understand the potential risks associated with different medications used in pregnancy, especially in individuals with pre-existing conditions like seizure disorders. This knowledge helps in making informed decisions regarding treatment strategies to optimize maternal and fetal health outcomes. It also highlights the importance of individualizing treatment plans based on the specific risks and benefits for each patient.
Carbamazepine (option A), Lamotrigine (option B), and Phenytoin (option C) are also commonly used antiepileptic drugs. However, they are generally considered to have a lower risk of cognitive impairment compared to Valproic acid. While they still pose some risks during pregnancy, they are often preferred over Valproic acid when managing seizure disorders in women of childbearing age due to their relatively safer profiles in terms of fetal neurodevelopment.
From an educational context, it is crucial for healthcare providers to understand the potential risks associated with different medications used in pregnancy, especially in individuals with pre-existing conditions like seizure disorders. This knowledge helps in making informed decisions regarding treatment strategies to optimize maternal and fetal health outcomes. It also highlights the importance of individualizing treatment plans based on the specific risks and benefits for each patient.